Interprofessional Perspectives on Safety Management With Targeted Therapy for B-cell Malignancies

All Live and On-Demand Activities

Filter Activities

Clear

Visualizing Progress in the Management of Chronic Spontaneous Urticaria: Harnessing the Clinical Potential of New and Novel Therapies to Address Unmet Patient Needs

0.5 hr(s) | CME

Specialty: Chronic Spontaneous Urticaria

Therapeutic Area(s): Dermatology

Release Date: November 11, 2021

Expiration Date: November 10, 2022

Location: Internet Activity Enduring

In this animated activity, an expert in dermatology discusses new and novel therapies addressing unmet patient needs in the management of chronic spontaneous urticaria (CSU).

Overcoming the Challenges of Diverse TGCT Presentations: Diagnostic and Treatment Principles for the Multidisciplinary Team

0.50 hr(s) | ABIM , CME , MOC , Royal College of Physicians and Surgeons of Canada

Specialty: tenosynovial giant cell tumor

Therapeutic Area(s): Oncology

Release Date: October 29, 2021

Expiration Date: October 28, 2022

Location: Internet Activity Enduring

Despite the widespread use of surgery as a standard of care for tenosynovial giant cell tumor (TGCT), several therapeutic challenges remain, particularly in the setting of diffuse TGCT, where recurrent and difficult-to-treat disease can be present. In this activity, an orthopedic surgeon and medical oncologist debate the case-based management of challenging TGCT presentations, and illustrate the nuances of multidisciplinary collaboration when managing patients with TGCT. Throughout, the panelists profile a modern management synthesis that combines surgery, physical therapy, and the use of targeted agents, including for patients for whom surgery alone is unlikely to be beneficial.

Integrating the Latest Evidence into Practice: Expert Insights on Targeted Biologic Therapy for Pediatric and Adult Patients with Moderate to Severe Atopic Dermatitis

0.50 hr(s) | CME

Specialty: Atopic Dermatitis

Therapeutic Area(s): Dermatology

Release Date: October 20, 2021

Expiration Date: October 19, 2022

Location: Internet Activity Enduring

In this activity, an expert dermatologist discusses the latest evidence from the 30th European Academy of Dermatology and Venereology Congress for current and emerging targeted biologic therapies for moderate to severe atopic dermatitis in adults and children.

Advancing Treatment of von Willebrand Disease: A Visual Exploration on Personalizing Care with Current and Emerging Management Strategies

0.50 hr(s) | CME

Specialty: von Willebrand Disease

Therapeutic Area(s): Hematology, Malignant

Release Date: October 15, 2021

Expiration Date: October 14, 2022

Location: Internet Activity Enduring

In this activity, a hematology expert discusses the diagnostic assessment and management of von Willebrand disease, as well as available treatment options and strategies for shared decision-making.

Strategies To Improve Glucose Control with Mealtime Insulin

1.5 hr(s) | CME , CPE , NCPD

Specialty: Diabetes , Endocrinology

Therapeutic Area(s): Diabetes , Endocrinology , Family Medicine / Primary Care

Release Date: September 30, 2021

Expiration Date: March 31, 2023

Location: Internet Activity Enduring

This CME/NCPD/CPE activity includes five individual interactive, microlearning modules addressing care and outcomes for individuals with diabetes treated with mealtime insulin (MTI).  The modules incorporate case studies with embedded questions for an active learning experience. Learners can choose to participate in one or more of the modules to address their educational interests and needs based on their scope of practice and patient population.

Strategies for Controlling Glucose with MTI

1.5 hr(s) | CME , CPE , NCPD

Specialty: Diabetes , Endocrinology

Therapeutic Area(s): Diabetes , Endocrinology

Release Date: September 30, 2021

Expiration Date: March 31, 2023

Location: Internet Activity Enduring Material

This CME/NCPD/CPE activity includes five individual interactive, microlearning modules addressing care and outcomes for individuals with diabetes treated with mealtime insulin (MTI). The modules incorporate case studies with embedded questions for an active learning experience. Learners can choose to participate in one or more of the modules to address their educational interests and needs based on their scope of practice and patient population.

Interprofessional Perspectives on Safety Management With Targeted Therapy for B-cell Malignancies

1.00 hr(s) | ABIM , CME , MOC , NCPD

Specialty: B-cell Malignancies

Therapeutic Area(s): Hematology, Malignant , Oncology

Release Date: October 4, 2021

Expiration Date: October 3, 2022

Location: Internet Activity Enduring

In this activity, a hematologist-oncologist, cardiologist, oncology nurse, and pharmacist team up to discuss targeted agents (including BTK and BCL-2 inhibitors) in B-cell malignancies and how the team works closely together to manage toxicity and safety concerns associated with targeted therapies. Case scenarios are presented to illustrate how a collaborative approach is not only necessary for managing patients with B-cell cancers, such as CLL and MCL, but can also improve patient outcomes through monitoring and managing adverse events.

1 2 3 4 5 6 7
Copy link
Powered by Social Snap